Results 41 to 50 of about 3,048,170 (258)

Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer

open access: yesJournal of Experimental & Clinical Cancer Research, 2017
Background Patients with metastatic or relapsed gallbladder cancer generally have a poor prognosis. Therefore, targeting metastasis is one arm of therapeutic strategies to treat gallbladder cancer.
Fei Zhang   +14 more
doaj   +1 more source

Acetylation stabilizes stathmin1 and promotes its activity contributing to gallbladder cancer metastasis

open access: yesCell Death Discovery, 2022
Gallbladder cancer is the most common biliary tract malignant tumor with highly metastatic characters and poor prognosis. However, the underlying mechanism remains unclear. Stathmin1 is ubiquitous phosphoprotein, regulating microtubule stabilization.
Kun Fan   +11 more
doaj   +1 more source

Gallbladder cancer: current and future treatment options

open access: yesFrontiers in Pharmacology, 2023
Surgery remains the preferred treatment option for early-stage gallbladder cancer (GBC). According to the anatomical position of the primary tumor, accurate preoperative stage and strict control of surgical indications, appropriate surgical strategies ...
Yanzhao Zhou   +14 more
doaj   +1 more source

Bladder-to-bladder metastasis: gallbladder cancer metastasising to the urinary bladder

open access: yes, 2021
We report a 48-year-old fit and healthy woman who was incidentally diagnosed to have adenocarcinoma of gallbladder after laparoscopic cholecystectomy. Subsequent imaging showed no evidence of regional or distant spread.
J. Abbaraju   +3 more
core   +1 more source

Disease Burden of Gallbladder Cancer in China from 1990 to 2019 and the Analysis of Its Future Trends [PDF]

open access: yesZhongguo quanke yixue
Background Gallbladder cancer is featured by difficult early detection, poor treatment effectiveness and high mortality. An in-depth epidemiology research of gallbladder cancer can provide valuable data for the formulation of prevention and treatment ...
LIU Shanshan, LI Chuyi, ZHENG Ying, LU Lixia, LI Bin, YU Xiaohui, DANG Zheng
doaj   +1 more source

Synchronous primary gallbladder and pancreatic cancer associated with congenital biliary dilatation and pancreaticobiliary maljunction

open access: yesSurgical Case Reports, 2017
Introduction Synchronous double cancer of the gallbladder and pancreas that is associated with congenital biliary dilatation (CBD) and pancreaticobiliary maljunction (PBM) is extremely rare. PBM is frequently reported in Asia, particularly in Japan.
Haruki Mori   +5 more
doaj   +1 more source

EGFR-targeted fluorescent imaging using the da Vinci® Firefly™ camera for gallbladder cancer

open access: yesWorld Journal of Surgical Oncology, 2022
Background Fluorescent imaging may aid with the precise diagnosis and treatment of patients with gallbladder cancer. In this study, we sought to demonstrate whether the da Vinci® surgical system and Firefly™ camera could detect EGFR-targeted fluorescent ...
Jung Ha Choi   +2 more
doaj   +1 more source

Arctigenin induced gallbladder cancer senescence through modulating epidermal growth factor receptor pathway

open access: yesTumor Biology, 2017
Gallbladder cancer has poor prognosis and limited therapeutic options. Arctigenin, a representative dibenzylbutyrolactone lignan, occurs in a variety of plants.
Mingdi Zhang   +11 more
doaj   +1 more source

Correlation of mechanical factors and gallbladder pain [PDF]

open access: yes, 2008
Acalculous biliary pain occurs in patients with no gallstones, but is similar to that experienced by patients with gallstones. Surgical removal of the gallbladder (GB) in these patients is only successful in providing relief of symptoms to about half of ...
Li, W.G.   +6 more
core   +1 more source

Clinicopathological and Molecular Insights into Gallbladder Cancer

open access: yes, 2023
Although gallbladder cancer (GBC) is rare, it is one of the few cancers with a higher mortality rate than incidence, accounting for 1 [...
Rachel S. van der Post   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy